Value of hepatic venous pressure gradient in preoperative evaluation and prognosis prediction in liver transplant recipients

Zhang Pengfei; Chen Yajie; Cao Jinglin; Zhao Caiyan; Wang Yang; Dou Jian

doi:10.3969/j.issn.1674-7445.2023.01.021

Volume 14 Issue 1

Jan. 2023

Turn off MathJax

Article Contents

Article Navigation > ORGAN TRANSPLANTATION > 2023 > 14(1): 154-159

Zhang Pengfei, Chen Yajie, Cao Jinglin, et al. Value of hepatic venous pressure gradient in preoperative evaluation and prognosis prediction in liver transplant recipients[J]. ORGAN TRANSPLANTATION, 2023, 14(1): 154-159. doi: 10.3969/j.issn.1674-7445.2023.01.021

Citation:

PDF( 1367 KB)

Value of hepatic venous pressure gradient in preoperative evaluation and prognosis prediction in liver transplant recipients

doi: 10.3969/j.issn.1674-7445.2023.01.021

Department of Hepatobiliary Surgery, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China

More Information

Corresponding author: Dou Jian, Email: 2423978344@qq.com
Received Date: 2022-08-23
Available Online: 2023-01-17
Publish Date: 2023-01-15

Abstract

Abstract

Hepatic venous pressure gradient (HVPG) is the "gold standard" for the diagnosis of portal hypertension, which could be applied in the evaluation of liver cirrhosis. Combined use of HVPG with model for end-stage liver disease (MELD) scoring system may more accurately match the donors and recipients undergoing liver transplantation for liver cirrhosis, select the appropriate timing of surgery, and provide guidance for bridging treatment for patients on the waiting list for liver transplantation. Besides, HVPG may also predict clinical prognosis of liver transplant recipients, and provide evidence for early detection and intervention of potential complications. Therefore, the value of HVPG in preoperative evaluation and prognosis prediction of liver transplant recipients was reviewed, aiming to provide guidance for clinical diagnosis and treatment of liver transplant recipients before and after surgery.

FullText(HTML)

References(31)

References

[1]	庄莉, 刘相艳. 肝移植受者围手术期管理及并发症预防与治疗[J]. 中华消化外科杂志, 2021, 20(10): 1037-1041. DOI: 10.3760/cma.j.cn115610-20210915-00459. ZHUANG L, LIU XY. Perioperative management and complications prevention and treatment of recipients in liver transplantation[J]. Chin J Dig Surg, 2021, 20(10): 1037-1041. DOI: 10.3760/cma.j.cn115610-20210915-00459.
[2]	李涛, 陈皓. 肝硬化门静脉高压症的肝移植治疗[J]. 外科理论与实践, 2021, 26(3): 189-194. DOI: 10.16139/j.1007-9610.2021.03.002. LI T, CHEN H. Liver transplantation for cirrhosis and portal hypertension[J]. J Surg Concepts Pract, 2021, 26(3): 189-194. DOI: 10.16139/j.1007-9610.2021.03.002.
[3]	吕少诚, 郎韧, 贺强. 肝硬化肝移植手术时机的选择与研究进展[J]. 解放军医学院学报, 2020, 41(8): 821-825. DOI: 10.3969/j.issn.2095-5227.2020.08.017. LYU SC, LANG R, HE Q, et al. Research advances in timing of liver transplantation for cirrhosis[J]. Acad J Chin PLA Med Sch, 2020, 41(8): 821-825. DOI: 10.3969/j.issn.2095-5227.2020.08.017.
[4]	王继涛, 祁小龙. 肝静脉压力梯度在肝硬化外科手术中的应用现状及前景[J]. 中华消化外科杂志, 2021, 20(10): 1113-1116. DOI: 10.3760/cma.j.cn115610-20210831-00424. WANG JT, QI XL. Application status and prospect of hepatic venous pressure gradient in liver cirrhosis surgery[J]. Chin J Dig Surg, 2021, 20(10): 1113-1116. DOI: 10.3760/cma.j.cn115610-20210831-00424.
[5]	BLASCO A, FORNS X, CARRIÓN JA, et al. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation[J]. Hepatology, 2006, 43(3): 492-499. DOI: 10.1002/hep.21090.
[6]	MATSUSHIMA H, FUJIKI M, SASAKI K, et al. Predictive value of hepatic venous pressure gradient for graft hemodynamics in living donor liver transplantation[J]. Liver Transpl, 2019, 25(7): 1034-1042. DOI: 10.1002/lt.25471.
[7]	KUMAR A, MARUYAMA H, ARORA A, et al. Diagnostic accuracy of transient elastography in diagnosing clinically significant portal hypertension in patients with chronic liver disease: a systematic review and meta-analysis[J]. J Med Ultrason (2001), 2022, 49(3): 333-346. DOI: 10.1007/s10396-022-01239-x.
[8]	MANDORFER M, HERNÁNDEZ-GEA V, GARCÍA-PAGÁN JC, et al. Noninvasive diagnostics for portal hypertension: a comprehensive review[J]. Semin Liver Dis, 2020, 40(3): 240-255. DOI: 10.1055/s-0040-1708806.
[9]	LIU C, SHAO R, WANG S, et al. The presence of ascites affects the predictive value of HVPG on early rebleeding in patients with cirrhosis[J]. Gastroenterol Res Pract, 2020: 1329857. DOI: 10.1155/2020/1329857.
[10]	蒋帆荣, 颜华东. 基于肝静脉压力梯度测定的代偿期肝硬化患者临床显著性门静脉高压的相关危险因素分析[J]. 中华肝脏病杂志, 2021, 29(10): 995-1000. DOI: 10.3760/cma.j.cn501113-20210829-00437. JIANG FR, YAN HD. Risk factors of clinically significant portal hypertension in patients with compensated liver cirrhosis based on hepatic venous pressure gradient[J]. Chin J Hepatol, 2021, 29(10): 995-1000. DOI: 10.3760/cma.j.cn501113-20210829-00437.
[11]	SOMSOUK M, KORNFIELD R, VITTINGHOFF E, et al. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk[J]. Liver Transpl, 2011, 17(2): 129-136. DOI: 10.1002/lt.22218.
[12]	LUCIDI C, GINANNI CORRADINI S, ABRALDES JG, et al. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: evidence by means of 2 independent cohorts[J]. Liver Transpl, 2016, 22(10): 1333-1342. DOI: 10.1002/lt.24517.
[13]	CHANG Y, SUK KT, JEONG SW, et al. Application of hepatic venous pressure gradient to predict prognosis in cirrhotic patients with a low model for end-stage liver disease score[J]. Diagnostics (Basel), 2020, 10(10): 805. DOI: 10.3390/diagnostics10100805.
[14]	GARCIA-TSAO G, FRIEDMAN S, IREDALE J, et al. Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis[J]. Hepatology, 2010, 51(4): 1445-1449. DOI: 10.1002/hep.23478.
[15]	RIPOLL C, BAÑARES R, RINCÓN D, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD era[J]. Hepatology, 2005, 42(4): 793-801. DOI: 10.1002/hep.20871.
[16]	何福亮, 欧晓娟, 王民, 等. 肝静脉压力梯度对肝硬化临床终点事件的预测[J]. 临床肝胆病杂志, 2020, 36(9): 1931-1935. DOI: 10.3969/j.issn.1001-5256.2020.09.004. HE FL, OU XJ, WANG M, et al. Value of hepatic venous pressure gradient in predicting clinical end events in liver cirrhosis[J]. J Clin Hepatol, 2020, 36(9): 1931-1935. DOI: 10.3969/j.issn.1001-5256.2020.09.004.
[17]	北京医师协会门静脉高压专科医师分会, 中国研究型医院学会肝病专业委员会门静脉高压学组, 中国研究型医院学会肝病专业委员会. 肝硬化门静脉高压症多学科诊治(基于肝静脉压力梯度)专家共识[J]. 临床肝胆病杂志, 2021, 37(9): 2037-2044. DOI: 10.3969/j.issn.1001-5256.2021.09.008. Beijing Society of Portal Hypertension of Beijing Medical Association, Portal Hypertension Expert Committee of Liver Disease Committee of Chinese Research Hospital Association, Liver Disease Committee of Chinese Research Hospital Association. Expert consensus on multidisciplinary diagnosis and treatment of cirrhotic portal hypertension (based on hepatic venous pressure gradient)[J]. J Clin Hepatol, 2021, 37(9): 2037-2044. DOI: 10.3969/j.issn.1001-5256.2021.09.008.
[18]	TÉLLEZ L, GUERRERO A, ALBILLOS A. Update on the diagnosis and management of portal hypertension in cirrhosis according to the Baveno VⅡ consensus conference recommendations[J]. Rev Esp Enferm Dig, 2022, 114(9): 534-542. DOI: 10.17235/reed.2022.8868/2022.
[19]	DIAZ-SOTO MP, GARCIA-TSAO G. Management of varices and variceal hemorrhage in liver cirrhosis: a recent update[J]. Therap Adv Gastroenterol, 2022, 15: 17562848221101712. DOI: 10.1177/17562848221101712.
[20]	NABILOU P, DANIELSEN KV, KIMER N, et al. Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: relation to severity?[J]. PLoS One, 2022, 17(6): e0270603. DOI: 10.1371/journal.pone.0270603.
[21]	KORSIC S, STABUC B, SKOK P, et al. TIPS vs. endoscopic treatment for prevention of recurrent variceal bleeding: a long-term follow-up of 126 patients[J]. Radiol Oncol, 2021, 55(2): 164-171. DOI: 10.2478/raon-2021-0006.
[22]	孙洪程, 徐洪雨. 门静脉压力评估方法的现状及研究进展[J]. 医学综述, 2021, 27(3): 534-539. DOI: 10.3969/j.issn.1006-2084.2021.03.022. SUN HC, XU HY. Status and research progress of portal vein pressure assessment methods[J]. Med Recap, 2021, 27(3): 534-539. DOI: 10.3969/j.issn.1006-2084.2021.03.022.
[23]	LIN JA, GARDNER JM, KOLLI KP, et al. Surgical, interventional, and medical palliation of portal hypertension[J]. Am Surg, 2020, 86(11): 1467-1472. DOI: 10.1177/0003134820965947.
[24]	JOTHIMANI D, VENUGOPAL R, VIJ M, et al. Post liver transplant recurrent and de novo viral infections[J]. Best Pract Res Clin Gastroenterol, 2020, 46/47: 101689. DOI: 10.1016/j.bpg.2020.101689.
[25]	RIPOLL C, GROSZMANN R, GARCIA-TSAO G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis[J]. Gastroenterology, 2007, 133(2): 481-488. DOI: 10.1053/j.gastro.2007.05.024.
[26]	KALAMBOKIS G, MANOUSOU P, SAMONAKIS D, et al. Clinical outcome of HCV-related graft cirrhosis and prognostic value of hepatic venous pressure gradient[J]. Transpl Int, 2009, 22(2): 172-181. DOI: 10.1111/j.1432-2277.2008.00744.x.
[27]	GONZÁLEZ IA, HARTLEY CP, NALBANTOGLU I. Recurrent autoimmune hepatitis and de novo autoimmune hepatitis in the liver allograft[J]. Am J Clin Pathol, 2021, 155(3): 435-445. DOI: 10.1093/ajcp/aqaa147.
[28]	TROISI RI, BERARDI G, TOMASSINI F, et al. Graft inflow modulation in adult-to-adult living donor liver transplantation: a systematic review[J]. Transplant Rev (Orlando), 2017, 31(2): 127-135. DOI: 10.1016/j.trre.2016.11.002.
[29]	MARÍN-GÓMEZ LM, BERNAL-BELLIDO C, ALAMO-MARTÍNEZ JM, et al. Intraoperative hepatic artery blood flow predicts early hepatic artery thrombosis after liver transplantation[J]. Transplant Proc, 2012, 44(7): 2078-2081. DOI: 10.1016/j.transproceed.2012.07.077.
[30]	RAMMOHAN A, RELA M, KIM DS, et al. Does modification of portal pressure and flow enhance recovery of the recipient after living donor liver transplantation? - a systematic review of literature and expert panel recommendations[J]. Clin Transplant, 2022, 36(10): e14657. DOI: 10.1111/ctr.14657.
[31]	赵晨, 张庆桥, 徐浩, 等. 采用Viabahn支架行经颈静脉肝内门体分流术治疗肝静脉广泛闭塞布加综合征的疗效分析[J]. 中华肝脏病杂志, 2021, 29(10): 972-976. DOI: 10.3760/cma.j.cn501113-20200331-00151. ZHAO C, ZHANG QQ, XU H, et al. Analysis of curative efficacy of transjugular intrahepatic portosystemic shunt using viabahn stent in the treatment of Budd-Chiari syndrome with extensive hepatic vein occlusion[J]. Chin J Hepatol, 2021, 29(10): 972-976. DOI: 10.3760/cma.j.cn501113-20200331-00151.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1)

Get Citation

PDF

XML

Article Metrics

Article views (254) PDF downloads(65)

Value of hepatic venous pressure gradient in preoperative evaluation and prognosis prediction in liver transplant recipients

doi: 10.3969/j.issn.1674-7445.2023.01.021

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Value of hepatic venous pressure gradient in preoperative evaluation and prognosis prediction in liver transplant recipients

doi: 10.3969/j.issn.1674-7445.2023.01.021

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content